Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
startups
boston blog main
boston top stories
life sciences
medical device
national blog main
tc
20/20 healthcare partners
alder biopharmaceutical
allergan
american academy of neurology
amgen
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
atogepant
biohaven
biology
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
christian angermayer
clinical trials
detroit blog main
detroit top stories
dolby family ventures
drugs
eli lilly
enclear therapies
endeavor
eptinezumab
erenumab
fda
financing
fremanezumab
What
new
4
×
therapies
4
×
companies
drugs
neuro
startup
accomplish
approval
arguments
associated
astonishing
big
biopharmaceutical
biotech
called
catching
celgene
cells
celularity
class
combinator’s
commercialized
company
competitors
creating
day
days
decades
demo
derived
develop
device
dialysis
diamandis
disease
diseases
dozen
drug
enclear
endeavor
Language
unset
Current search:
new
×
biotech
×
therapies
×
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas